EPS for Omnicell, Inc. (OMCL) Expected At $-0.04 as of May, 3

James Marshall
April 17, 2018

The stock was sold at an average price of $38.06, for a total value of $131,040.58. The institutional investor held 11,596 shares of the technology company at the end of 2017Q4, valued at $562,000, down from 43,347 at the end of the previous reported quarter. Omnicell, Inc. has a 1-year low of $25.06 and a 1-year high of $40.50. The stock increased 0.34% or $0.11 during the last trading session, reaching $32.06. Omnicell, Inc. (NASDAQ:OMCL) has risen 5.20% since April 15, 2017 and is uptrending. The stock underperformed the S&P 500 by 6.35%.

Bbr Partners Llc increased its stake in Ellington Financial Llc (EFC) by 45.85% based on its latest 2017Q4 regulatory filing with the SEC. The hedge fund run by Joseph Edelman held 70,585 shares of the health care company at the end of 2017Q4, valued at $25.76 million, up from 25,195 at the end of the previous reported quarter. Daruma Capital Management Llc who had been investing in Omnicell Inc for a number of months, seems to be less bullish one the $1.75B market cap company. The stock decreased 2.18% or $0.76 during the last trading session, reaching $34.07. About 5.73 million shares traded.

During Q4 2017 the big money sentiment increased to 1.12. The firm has a market capitalization of $1,756.37, a P/E ratio of 248.61, a PEG ratio of 3.73 and a beta of 0.74. It increased, as 14 investors sold Omnicell, Inc. shares while 72 reduced holdings. 27 funds opened positions while 69 raised stakes. Blackrock has 4.84M shares. Kepos Cap Ltd Partnership reported 194,047 shares.

Omnicell, Inc (Omnicell) is a provider of automation and business information solutions created to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. (NASDAQ:OMCL) for 82,739 shares. Harris Associate LP holds 0.01% or 37,750 shares in its portfolio. During the same quarter last year, the firm posted $0.37 EPS. research analysts expect that Omnicell Technologies will post 0.77 EPS for the current fiscal year. (NASDAQ:OMCL) for 17,416 shares. (NASDAQ:OMCL). The Alaska-based State Of Alaska Department Of Revenue has invested 0.01% in Omnicell, Inc.

Vanguard Group accumulated 0.01% or 2.71M shs. Rockefeller Fin invested in 0.36% or 469,672 shares. Keybank Association Oh invested in 0% or 6,342 shares. First Light Asset Management Limited Co stated it has 4.22% of its portfolio in Omnicell, Inc. Natixis reported 69,811 shs. Strs Ohio holds 0.01% or 70,000 shares. (NASDAQ:OMCL) on Thursday, March 15. Zacks Investment Research downgraded shares of Omnicell from a "hold" rating to a "strong sell" rating in a research report on Tuesday, January 24th.

Since December 15, 2017, it had 0 buys, and 4 selling transactions for $520,345 activity. Over the last 90 days, insiders have sold 9,485 shares of company stock valued at $420,754.

Analysts await Omnicell, Inc. After $-0.24 actual earnings per share reported by Transocean Ltd. for the previous quarter, Wall Street now forecasts 16.67% negative EPS growth. Following the transaction, the insider now owns 56,970 shares of the company's stock, valued at $2,620,620. Sei Investments Co. lifted its position in Omnicell Technologies by 76.7% during the 3rd quarter. (NASDAQ:OMCL). Stephens Management Limited Liability stated it has 0.47% of its capital in Omnicell, Inc. Therefore 70% are positive. Transocean Ltd had 109 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, December 5 the firm earned "Buy" rating by Oppenheimer. The stock has "Buy" rating by Cantor Fitzgerald on Tuesday, December 5. Craig Hallum maintained Omnicell, Inc. Zacks Investment Research downgraded shares of Omnicell Technologies from a "hold" rating to a "sell" rating in a report on Wednesday, January 10th. Oppenheimer restated a "buy" rating and issued a $55.00 target price on shares of Omnicell Technologies in a research note on Monday, January 29th. L & S Advisors Inc sold 7,023 shares as Microsoft Corporation (MSFT)'s stock rose 4.63%. As per Friday, July 31, the company rating was maintained by Topeka Capital Markets. The firm has "Buy" rating given on Wednesday, June 14 by Cowen & Co. PiperJaffray maintained it with "Neutral" rating and $44 target in Friday, February 2 report. The firm has "Neutral" rating given on Thursday, November 2 by Citigroup. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company. BMO Capital Markets has "Hold" rating and $25.0 target. As per Tuesday, August 22, the company rating was maintained by Keefe Bruyette & Woods. BMO Capital Markets maintained it with "Buy" rating and $38 target in Wednesday, April 12 report. Vetr upgraded the stock to "Hold" rating in Thursday, September 3 report. On Friday, June 23 the stock rating was reinitiated by JP Morgan with "Neutral". Oppenheimer maintained the shares of OMCL in report on Thursday, October 19 with "Buy" rating.

Investors sentiment increased to 1.12 in 2017 Q4. Its up 11.44, from 1.04 in 2017Q3. About 7.47 million shares traded. 69 funds opened positions while 101 raised stakes. Thomson Horstmann Bryant reported 115,826 shares. Eagle Asset Management Inc. boosted its position in shares of Omnicell Technologies by 36.8% during the fourth quarter. Following the sale, the chairman now directly owns 224,206 shares in the company, valued at $9,912,147.26. 15,689 are held by Bnp Paribas Arbitrage. Riverhead Cap Management Limited Liability Co holds 0.03% or 67,020 shares. Ftb Advisors Incorporated reported 900 shs. Kennedy Cap has 465,483 shares. Foundry Prns Lc stated it has 40,394 shares or 0.08% of all its holdings. Sfe Invest Counsel reported 0.29% stake. (NASDAQ:ISRG). Kentucky Retirement Insurance Trust Fund has 0.18% invested in Intuitive Surgical, Inc. Convergence Invest Ptnrs Limited Liability, Wisconsin-based fund reported 105,775 shares.

Since February 27, 2018, it had 1 insider buy, and 0 insider sales for $33,154 activity. Shares for $5.57M were sold by BARRATT CRAIG H on Tuesday, October 24. LIPPS RANDALL A had sold 8,186 shares worth $361,938.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER